A Study to Assess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Cardiac Sarcoidosis A Study to Assess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Ca ...
A Randomized, Double-blind, Placebo-controlled, Phase 2a Study With an Open-label Cohort to Assess the Safety, Tolerability, and Efficacy of Namilumab in Subjects With Active Cardiac Sarcoidosis A Randomized, Double-blind, Placebo-controlled, Phase 2a Study With an Open-label Cohort to Assess t ...